trial · primary record
0.75% phentolamine ophthalmic solution
Presbyopia
| Phase | Phase 3 |
|---|---|
| Status | COMPLETED |
| Sponsor | Unknown |
| Enrolment | 569 |
| Primary completion | 2026-01-22 |
| Primary endpoint | Percentage of Subjects With ≥ 15 Letters of Improvement in Binocular DCNVA and With < 5 Letters of Loss in Binocular BCDVA From Baseline Comparing POS-treated Participants to Placebo-treated Participants at 12 Hours Post-dose at Visit 4 (Day 8) |
| Registry ID | NCT06542497 |
Provenance
- Source: ClinicalTrials.gov
- Fetched at: 2026-10-28T02:33:03.411Z
- Licence class: attribution-required
- Verdict: primary-source
- Entity id: NCT06542497
This record is rendered from the AEaH spine. If the source is unreachable the page is not generated.